Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions

Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)1,000 enrolled

Overview

The goal of this observational study is to To assess the prevalence and patterns of dietary supplement use among patients with cancer and to analyze the impact of these supplements in the context of anticancer medical treatments, including chemotherapy, targeted therapies, hormone therapy, and immunotherapies. The main questions it aims to answer : * What is the prevalence of dietary supplement use among cancer patients, and what is their tolerance profile? * Are there any potential drug interactions between dietary supplements and anticancer medications? Participants will: * Provide sociodemographic information, including age, sex, educational level, and other relevant characteristics. * Report their use of dietary supplements, including the types of supplements consumed (e.g., vitamins, minerals, herbal products), dietary practices, frequency and duration of use, and reasons for consumption (e.g., medical recommendation or self-medication). * Report any perceived adverse effects related to dietary supplement use to assess tolerance. * Allow the collection of relevant clinical data from their medical records, including cancer type, ongoing anticancer treatments, and treatment-related adverse effects.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Cancer (Solid Tumors)Interaction Drug Food

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with cancer and receiving medical anticancer treatment, including chemotherapy, hormone therapy, immunotherapy, and targeted therapies. * Current or recent use of one or more dietary supplements (e.g., vitamins, minerals, herbal products, or other nutritional supplements). * Adult patients : \>=18 Exclusion Criteria: * Patients unable to complete the study questionnaire because of cognitive impairment or a deteriorated health condition. * Failure or refusal to provide written informed consent.

Outcomes

Primary Outcomes

Prevalence of Dietary Supplement Use and Tolerance

Assessment of the prevalence of dietary supplement use among cancer patients and evaluation of adverse effects associated with dietary supplement consumption.

Time frame: At enrollment

Potential Drug-Supplement Interactions

Assessment of potential interactions between dietary supplements and anticancer medications

Time frame: At enrollment or single study visit

Secondary Outcomes

Potential Drug-Supplement Interactions Assessed by Artificial Intelligence

Assessment of potential interactions between dietary supplements and anticancer treatments using Hedrine software.

Time frame: At enrollment or Single study visit